Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
ID : MRI14154 | Date : Feb, 2021 | Pages :
180 | Region : Global |
Publisher : RI
The Non-steroidal Anti-inflammatory Drugs (NSAID) market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Non-steroidal Anti-inflammatory Drugs (NSAID) market size is expected to gain market growth in the forecast period of 2020 to 2028, with a CAGR of xx%% in the forecast period of 2020 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
By Application
Human
Animals
Others
Competitive Landscape and Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
Non-steroidal Anti-inflammatory Drugs (NSAID) competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Non-steroidal Anti-inflammatory Drugs (NSAID) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-steroidal Anti-inflammatory Drugs (NSAID) sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-steroidal Anti-inflammatory Drugs (NSAID) market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-steroidal Anti-inflammatory Drugs (NSAID) markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-steroidal Anti-inflammatory Drugs (NSAID) market.
Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Non-steroidal Anti-inflammatory Drugs (NSAID) market for the forecast period 2020 - 2028?
• What are the driving forces in the Non-steroidal Anti-inflammatory Drugs (NSAID) market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Non-steroidal Anti-inflammatory Drugs (NSAID) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
1 Study Coverage
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Product
1.4.2 Salicylates
1.4.3 Propionic acid derivatives
1.4.4 Acetic acid derivatives
1.4.5 Enolic acid (Oxicam) derivatives
1.4.6 Anthranilic acid derivatives (Fenamates)
1.4.7 Selective COX-2 inhibitors (Coxibs)
1.4.8 Sulfonanilides
1.5 Market by End User
1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by End User
1.5.2 Human
1.5.3 Animals
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size
2.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2015-2028
2.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2015-2028
2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Growth Rate by Regions
2.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Regions
2.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers
3.1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers
3.1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers
3.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Ratio (CR5 and HHI)
3.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers
3.2.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2015-2020)
3.2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2015-2020)
3.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturers
3.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution, Product Types
3.4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
3.4.3 Date of International Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs (NSAID) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Product
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Product
4.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Breakdown Data by End User
6 North America
6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) by Countries
6.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Countries
6.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) by Product
6.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) by End User
7 Europe
7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) by Countries
7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Countries
7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) by Product
7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) by End User
8 Asia Pacific
8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) by Countries
8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Countries
8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) by Product
8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) by End User
9 Central & South America
9.1 Central & South America Non-steroidal Anti-inflammatory Drugs (NSAID) by Countries
9.1.1 Central & South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Countries
9.1.2 Central & South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Non-steroidal Anti-inflammatory Drugs (NSAID) by Product
9.3 Central & South America Non-steroidal Anti-inflammatory Drugs (NSAID) by End User
10 Middle East and Africa
10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) by Countries
10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Countries
10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) by Product
10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) by End User
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Business Overview
11.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.1.5 Bayer Recent Development
11.2 Ecotrin
11.2.1 Ecotrin Company Details
11.2.2 Company Business Overview
11.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.2.5 Ecotrin Recent Development
11.3 Generic
11.3.1 Generic Company Details
11.3.2 Company Business Overview
11.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.3.5 Generic Recent Development
11.4 St. Joseph
11.4.1 St. Joseph Company Details
11.4.2 Company Business Overview
11.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.4.5 St. Joseph Recent Development
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Company Business Overview
11.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.5.5 Elanco Recent Development
11.6 Zoetis
11.6.1 Zoetis Company Details
11.6.2 Company Business Overview
11.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.6.5 Zoetis Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Company Business Overview
11.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.7.5 Boehringer Ingelheim Recent Development
11.8 Merial
11.8.1 Merial Company Details
11.8.2 Company Business Overview
11.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.8.5 Merial Recent Development
11.9 Merck Animal Health
11.9.1 Merck Animal Health Company Details
11.9.2 Company Business Overview
11.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
11.9.5 Merck Animal Health Recent Development
12 Future Forecast
12.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast by Regions
12.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Regions 2021-2028
12.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Regions 2021-2028
12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast by Product
12.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Product 2021-2028
12.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Product 2021-2028
12.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast by End User
12.4 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Forecast
12.5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Forecast
12.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Forecast
12.7 Central & South America Non-steroidal Anti-inflammatory Drugs (NSAID) Forecast
12.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Forecast
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.
